切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-HT7 Receptors - ULK1 - BTK - CSF-1R

10 件产品

每页
清除全部
  1. ACP-196
    B6185 ACP-196
    中文名: 阿卡替尼
    Target: BTK
    Summary: 不可逆的BTK抑制剂
      ≥46.6 mg/mL
      insoluble in H2O
  2. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: 酪氨酸激酶抑制剂(TKI)
      ≥10.62 mg/mL
      ≥168.2 mg/mL
  3. SBI-0206965
    A8715 SBI-0206965
     2 Citation
    Target: ULK1
    Summary: ULK1抑制剂
      ≥24.47 mg/mL
      insoluble in H2O
  4. BLZ945
    B4899 BLZ945
     1 Citation
    Target: CSF-1R
    Summary: CSF-1R激酶抑制剂
      ≥19.9 mg/mL
      insoluble in H2O
  5. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  6. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  7. GW2580
    A1655 GW2580
     1 Citation
    Target: CSF-1R
    Summary: CFMS激酶/CSF-1R抑制剂
      ≥36.6 mg/mL
      insoluble in H2O
  8. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  9. CGI-1746
    A3302 CGI-1746
     1 Citation
    Target: BTK
    Summary: Btk抑制剂
      ≥29 mg/mL
      insoluble in H2O
  10. Pazopanib (GW-786034)
    A3022 Pazopanib (GW-786034)
    中文名: 帕唑帕尼
    Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFR
    Summary: (GW-786034)VEGFR/PDGFR/FGFR 的抑制剂。
      ≥10.95 mg/mL
      insoluble in H2O

10 件产品

每页